Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Arbutus Biopharma Corporation logo

Arbutus Biopharma Corporation

Sector: Healthcare   

Industry: Biotechnology

3.75
 
USD
  
0.16
  
(4.46%)
Optionable: Yes  Market Cap: 642 M  90-day average vol: 956,031

Previous close: 3.59  Open: 3.54  Bid: 3.7  Ask: 3.76
52 week range    
1.69   
   3.79
Last updated: Tuesday 16th July 2024

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)
Financials

ABUS Income Statement

Annual
Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22Dec-23
AccruedPreferredStockDividends911000.010 M11 M12 M12 M
Basic EPS from continuing operations-1.0-0.83-0.46-0.44
Basic EPS total-1.8-1.34-7.24-1.56-1.21-0.46-1.0-0.83-0.46-0.44
Basic weighted shares outstanding22 M45 M53 M55 M55 M57 M76 M106 M151 M166 M
Cost of sales47 M
Depreciation529000.0589000.01 M2 M2 M2 M2 M2 M1 M1 M
Depreciation unreconciled529000.0589000.01 M2 M2 M2 M2 M
DepreciationAndAmortization529000.0589000.01 M2 M2 M2 M2 M2 M1 M1 M
Diluted EPS total-1.8-1.34-7.24-1.56-1.21-2.89-1.0-0.83-0.46-0.44
Diluted normalized net income/share-0.83-0.46-0.44
Diluted weighted shares outstanding22 M45 M53 M55 M79 M37 M106 M151 M166 M
Earnings from equity interest-6 M-23 M-3 M
EarningsFromEquityInterestNetOfTax-6 M-23 M-3 M
GainOnSaleOfSecurity25 M100000.0100000.0
GeneralAndAdministrativeExpense9 M26 M39 M16 M16 M18 M15 M17 M18 M22 M
Gross operating profit15 M25 M1 M11 M6 M6 M-41 M11 M39 M18 M
ImpairmentOfCapitalAssets138 M22 M
Income before tax-39 M-77 M-489 M-109 M-61 M-166 M-64 M-76 M-65 M-73 M
Income restructuring and M&A56 M109 M5 M156000.064000.01 M
Income taxes-3 M-16 M-105 M-24 M-4 M-13 M4 M
Interest income853000.0-96000.0823000.0179000.0-9 M2 M741000.0127000.02 M6 M
InterestExpenseNonOperating261000.0226000.02 M4 M3 M2 M459000.0
MiscOtherSpecialCharges-10 M3 M530000.0-22000.0
Net income from total operations-39 M-61 M-384 M-84 M-96 M-154 M-64 M-76 M-69 M-73 M
NetIncomeCommonStockholders-39 M-61 M-384 M-85 M-106 M-165 M-76 M-88 M-69 M-73 M
NetIncomeContinuousOperations-39 M-61 M-384 M-84 M-96 M-154 M-64 M-76 M-69 M-73 M
NetIncomeDiscontinuousOperations3 M
NetNonOperatingInterestIncomeExpense853000.0-96000.0823000.0-82000.0-9 M3000.0-3 M-3 M466000.05 M
NonRecurringOperationExpense6 M
Operating income-33 M-54 M-100 M-70 M-70 M-71 M-58 M-74 M-65 M-78 M
Operating income before depreciation (EBITDA)-38 M-77 M-488 M-106 M-59 M-163 M-58 M-72 M-62 M-71 M
OperatingExpense-48 M-127 M-493 M-122 M-96 M-150 M65 M85 M104 M96 M
Other income net11 M45 M253 M41 M15 M66 M3 M2 M2 M69000.0
OtherGandA9 M26 M39 M16 M16 M18 M15 M17 M18 M22 M
OtherImpairmentOfCapitalAssets39 M253 M41 M15 M44 M
OtherOperatingExpenses700000.0700000.0700000.0600000.0
OtherTaxes-52000.0-196000.0-145000.0-183000.0-18000.0
OtherunderPreferredStockDividend911000.010 M11 M12 M12 M
PreferredStockDividends911000.010 M11 M12 M12 M
ProvisionForGainLossOnDisposal3 M
RentAndLandingFees9 M26 M39 M16 M16 M18 M
Research & development expense39 M52 M61 M63 M58 M58 M49 M66 M84 M74 M
ResearchExpense39 M52 M61 M63 M58 M58 M49 M66 M84 M74 M
RestructringAndMnAIncome56 M109 M5 M156000.064000.01 M
SalariesAndWages-3 M-22 M-39 M-15 M-6 M-7 M200000.0300000.0200000.0200000.0
Selling Gen & administrative expense9 M26 M39 M16 M16 M18 M15 M17 M18 M22 M
Special income/charges-56 M-109 M-138 M-5 M-29 M-64000.0-1 M
Total Income available for interest expense (EBIT)-39 M-77 M-489 M-108 M-61 M-164 M-60 M-73 M-63 M-72 M
Total common shares outstanding47 M55 M55 M55 M56 M69 M96 M149 M163 M179 M
Total net income-39 M-61 M-384 M-84 M-96 M-154 M-64 M-76 M-69 M-73 M
Total ordinary shares189 M189 M189 M189 M189 M189 M189 M189 M189 M189 M
Total revenues15 M25 M1 M11 M6 M6 M7 M11 M39 M18 M
TotalExpenses-48 M-127 M-493 M-122 M-96 M-150 M65 M85 M104 M96 M
TotalRevenue15 M23 M1 M11 M6 M6 M7 M11 M39 M18 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University